| Pharmaceutical Information |
| Drug Name |
Fibrinogen |
| Drug ID |
BADD_D00895 |
| Description |
Fibrinogen concentrate (human) is a hematological agent. It works by replacing a certain protein in the blood that helps with blood clotting. Fibrinogen (factor I) is a soluble plasma glycoprotein with a molecular weight of about 340 kDa. It is a physiological substrate for three enzymes: plasmin, factor XIIIa and thrombin. It is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. |
| Indications and Usage |
For the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. |
| Marketing Status |
Not Available |
| ATC Code |
B02BB01; B02BC30 |
| DrugBank ID |
DB09222
|
| KEGG ID |
C00393
|
| MeSH ID |
D005340
|
| PubChem ID |
90540
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
63833-891 |
| Synonyms |
Fibrinogen | Blood Coagulation Factor I | Coagulation Factor I | Factor I, Coagulation | Factor I | gamma-Fibrinogen | gamma Fibrinogen |
|
| Chemical Information |
| Molecular Formula |
C6H14O6 |
| CAS Registry Number |
25878-23-3 |
| SMILES |
C(C(C(C(C(CO)O)O)O)O)O |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
